Roche was founded in Basel in 1896. Although the company began establishing operations abroad in the same year and today employs people in around 150 countries, Switzerland is still home to the Group’s headquarters and remains an important operational centre – not just a market.

The Roche companies operating in Northwestern and Central Switzerland and in the cantons of Berne and Zurich play a key role in the global research and production network. Roche medicines and Roche diagnostic systems from Switzerland are supplied to patients, physicians, hospitals, pharmacies and laboratories throughout the world.

Roche is one of the largest Swiss companies on the stock market in terms of market capitalisation. The great majority of people who own shares of Roche Holding Ltd, listed on the SWX Swiss Exchange, are residents of Switzerland. At the same time, just over half of the voting shares are held by the descendents of the company’s founders; as a result, the stability and strength of the ownership structure are almost unrivalled anywhere in the world.

For further information about Roche, please have a look at our brochure.